ArticleCurrent oncology (Toronto, Ont.)2022

Serology-Based Model for Personalized Epithelial Ovarian Cancer Risk Evaluation.

Tianqing Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.